Relating to liability shield products

HB 3477 requires manufacturers of "liability shield products" (medical/pharmaceutical/biological/technological products with federal liability immunity) to conduct placebo-controlled safety studies before marketing in West Virginia. It mandates that these studies track specific safety metrics (allergenicity, carcinogenicity, etc.) for five years, with results made publicly available on the Department of Health website. The bill also requires the Department to monitor adverse outcomes using existing health data systems, publish post-market surveillance data, and issue alerts about safety concerns. Additionally, it grants individuals the right to refuse such products without coercion. This proposed legislation applies to manufacturers distributing these products in West Virginia and is currently in committee review.